2 recruiting. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Recruiting 2 |
Follow Venous Thromboembolism (VTE): new trials by email Literature Review of Venous Thromboembolism (VTE) trials Research Report on Venous Thromboembolism (VTE)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Profile of YKYY033 Injection YKYY033 Injection, YKYY033 Placebo - Venous Thromboembolism (VTE) | Phase 1 | Recruiting | Beijing Youcare Kechuang Pharmaceutical Technology Co., Ltd. | 40 | 2026-07-10 | 2026-08-26 |
| A Single Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of CITY-FXI in Healthy Adults, Adults With FV Leiden or Prothrombin G20210A Mutation, and Adults With a History of Provoked Venous Thromboembolism CITY-FXI, Placebo - Factor V Leiden, Prothrombin G20210A | Phase 1 | Recruiting | City Therapeutics | 182 | 2026-01-22 | 2026-09-25 |
Cardiovascular Diseases (2) · Embolism and Thrombosis (2) · Thromboembolism (2) · Vascular Diseases (2)
Beijing Youcare Kechuang Pharmaceutical Technology Co., Ltd. (1) · City Therapeutics (1)
China (1) · United Kingdom (1)